SAMUEL B WILSON, M.D.
Osteopathic Medicine at Landsdowne St, Cambridge, MA

License number
Massachusetts 204052
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address 2
65 Landsdowne St, Cambridge, MA 02138
33 Homestead St, Lexington, MA 02421
Phone
(617) 768-8883

Organization information

See more information about SAMUEL B WILSON at bizstanding.com

Samuel B Wilson MD

65 Landsdowne St, Cambridge, MA 02139

Categories:
Government Contractors, Internal Medicine Physicians & Surgeons
Phone:
(617) 726-3815 (Phone)

Professional information

Samuel B Wilson Photo 1

Dr. Samuel B Wilson, Cambridge MA - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
65 Landsdowne St, Cambridge 02139
(617) 768-8883 (Phone)
Languages:
English
Education:
Medical School
Case Western Reserve University School Of Medicine
Graduated: 1990


Samuel Wilson Photo 2

Compositions And Methods Of Monoclonal And Polyclonal Antibodies Specific For T Cell Subpopulations

US Patent:
8138314, Mar 20, 2012
Filed:
Oct 2, 2006
Appl. No.:
11/541958
Inventors:
Mark A. Exley - Chestnut Hill MA, US
Samuel B. Wilson - Lexington MA, US
Steven P. Balk - Needham MA, US
Assignee:
Beth Israel Deaconess Medical Center, Inc. - Boston MA
Dana-Farber Cancer Institute - Boston MA
The General Hospital Corporation - Boston MA
International Classification:
C12P 21/08
US Classification:
5303873, 53038822
Abstract:
The invention provides compounds and methods for the ex vivo or in vivo expansion of NK T cells, CD1d-reactive T cells, and JαQ T cells, and the modulation of their activities. These compounds and methods have diagnostic and therapeutic applications.


Samuel Wilson Photo 3

Compositions And Methods Of Monoclonal And Polyclonal Antibodies Specific For T Cell Subpopulations

US Patent:
2002016, Nov 7, 2002
Filed:
Jun 19, 2001
Appl. No.:
09/885768
Inventors:
Mark Exley - Chestnut Hill MA, US
Samuel Wilson - Lexington MA, US
Steven Balk - Needham MA, US
International Classification:
A61K039/395, C07K016/28
US Classification:
424/144100, 530/388220
Abstract:
The invention provides compounds and methods for the ex vivo or in vivo expansion of NK T cells, CD1d-reactive T cells, and JQ T cells, and the modulation of their activities. These compounds and methods have diagnostic and therapeutic applications.